Brief: Alligator Bioscience Q3 EBIT SEK -62 Million
24/10/2024 07:00
Oct 24 (Reuters) - Alligator Bioscience Q3 adjusted EPS SEK -0.09. * Q3 revenue SEK 1.4 million * Q3 net income SEK -66.5 million
Recent news on Alligator Bioscience AB
See all newsSweden's Alligator Bioscience Q3 sales fall as R&D winds down
Brief: Alligator Bioscience Q3 EBIT SEK -19.3 Million
Brief: Alligator Bioscience Appoints Johan Gileus As CEO
Brief: Alligator Bioscience Announces Final Outcome In Rights Issue
Brief: Alligator Bioscience To Initially Receive SEK 58.8 Mln From Rights Issue